|
ERLEC1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.194000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.652000E-01 |
| Normal-vs-Stage2 |
4.002000E-01 |
| Normal-vs-Stage3 |
6.900400E-01 |
| Normal-vs-Stage4 |
2.935200E-01 |
| Stage1-vs-Stage2 |
4.159800E-01 |
| Stage1-vs-Stage3 |
5.672400E-01 |
| Stage1-vs-Stage4 |
1.216180E-01 |
| Stage2-vs-Stage3 |
3.186000E-01 |
| Stage2-vs-Stage4 |
1.315200E-01 |
| Stage3-vs-Stage4 |
6.607200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.094200E-01 |
| Normal-vs-AfricanAmerican |
1.177230E-01 |
| Normal-vs-Asian |
8.607800E-01 |
| Caucasian-vs-AfricanAmerican |
4.052300E-02 |
| Caucasian-vs-Asian |
8.507200E-01 |
| AfricanAmerican-vs-Asian |
3.117800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.083800E-01 |
| Normal-vs-Female |
9.601800E-01 |
| Male-vs-Female |
9.403800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.688200E-02 |
| Normal-vs-Age(41-60Yrs) |
8.620000E-01 |
| Normal-vs-Age(61-80Yrs) |
9.869400E-01 |
| Normal-vs-Age(81-100Yrs) |
7.686400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.575550E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.799500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.677000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.311000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.236800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.279200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.378200E-01 |
| Normal-vs-Grade 2 |
4.495800E-01 |
| Normal-vs-Grade 3 |
2.791000E-01 |
| Normal-vs-Grade 4 |
3.841600E-01 |
| Grade 1-vs-Grade 2 |
9.724200E-01 |
| Grade 1-vs-Grade 3 |
2.993200E-01 |
| Grade 1-vs-Grade 4 |
3.630400E-01 |
| Grade 2-vs-Grade 3 |
4.456300E-02 |
| Grade 2-vs-Grade 4 |
1.095420E-01 |
| Grade 3-vs-Grade 4 |
9.767800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.580400E-01 |
| Normal-vs-ccB subtype |
8.043000E-01 |
| ccA subtype-vs-ccB subtype |
6.452200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.421800E-01 |
| Normal-vs-N1 |
5.333400E-01 |
| N0-vs-N1 |
7.670000E-01 |
|
|
